Prosecution Insights
Last updated: April 19, 2026

Creative Medical Technologies Inc.

18 pending office actions

Portfolio Summary

18
Total Pending OAs
2
Final Rejections
16
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18366527 PROPHYLAXIS AND TREATMENT OF ORTHOPOX VIRUSES USING REGENERATIVE CELLS AND PRODUCTS THEREOF MOORE, JOHN DAVID 1638 Non-Final OA Aug 07, 2023
18366539 PREVENTION OF SPACE TRAVEL ASSOCIATED BONE DENSITY LOSS BY REGENERATIVE CELL POPULATIONS VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Aug 07, 2023
18363642 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS NGUYEN, NGHI V 1653 Non-Final OA Aug 01, 2023
18358490 POTENTIATION OF BONE MARROW CELL ACTIVITY BY COADMINISTRATION WITH OXYTOCIN ABEYRATNE-PERERA, HASHANTHI KOMITIGE 1632 Non-Final OA Jul 25, 2023
18348292 TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT CANDELARIA, JULIANA IRENE 1634 Non-Final OA Jul 06, 2023
18348288 OVERCOMING TNF-ALPHA BLOCKADE RESISTANCE IN RHEUMATOID ARTHRITIS BY REGENERATIVE T REGULATORY CELL THERAPY GAMETT, DANIEL C 1647 Non-Final OA Jul 06, 2023
18331048 GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED ENDOTHELIAL PROGENITOR CELLS KASAYAN, KATRIEL BARCELLANO 1634 Non-Final OA Jun 07, 2023
18311625 CYTOKINE PRIMED REGENERATIVE CELLS FOR TREATMENT OF OVARIAN FAILURE KASAYAN, KATRIEL BARCELLANO 1634 Non-Final OA May 03, 2023
18311445 CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION JONES, REESHEDA TAMIKA 1796 Non-Final OA May 03, 2023
18311474 STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS ALDARONDO, DASIA ALI 1647 Non-Final OA May 03, 2023
18300210 ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL KIM, TAEYOON 1631 Non-Final OA Apr 13, 2023
18183900 THERAPEUTIC REGENERATIVE CELLS REGLAS, GILLIAN CHELSEA 1632 Non-Final OA Mar 14, 2023
18173052 METHODS FOR QUANTIFYING POTENCY OF REGENERATIVE IMMUNOTHERAPIES YOUTCHOM PENDIE, EMMANUEL LED 1647 Non-Final OA Feb 22, 2023
18082841 CHIMERIC ANTIGEN RECEPTOR REGENERATIVE GAMMA DELTA T CELLS BELYAVSKYI, MICHAIL A 1644 Final Rejection Dec 16, 2022
18082857 REGENERATIVE CAR-T CELLS RAHMAN, MASUDUR 1633 Non-Final OA Dec 16, 2022
17931868 SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS BUNNER, BRIDGET E 1647 Final Rejection Sep 13, 2022
17865881 Therapeutic Monocytic Lineage Cells JOHNSON, ALLISON MARIE 1638 Non-Final OA Jul 15, 2022
17585356 TREATMENT OF KIDNEY FAILURE USING EX VIVO REPROGRAMMED IMMUNE CELLS STONEBRAKER, ALYSSA RAE 1642 Non-Final OA Jan 26, 2022

Managing Creative Medical Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month